NMRA Earnings
Wednesday, May 06 2026
EPS Estimate
$-0.31
$-0.36 – $-0.26
Current Price
$2.19
Our Position
neutralNMRA-511 Phase 1b clears agitation endpoint, heads to higher doses
structured data
est. revisions rising
(+3.1pp / 30d)
Early-stage biotech advances hinge on de-risking molecule safety before broader efficacy testing. NMRA-511 passing Phase 1b without major safety flags keeps the program on track — this is table stakes, not a victory lap. The real inflection comes if higher dose cohorts show dose-dependent efficacy signals without safety degradation.
Watch: Higher dose testing results in late 2026 or early 2027 will determine whether agitation reduction scales and whether the safety window remains intact. Timing and interim data releases matter — any safety signals or efficacy plateau derail the narrative fast.
Data Signal Summary
3 bullish
1 bearish
Estimates up +3%
Insider buying cluster
Put/call 0.2 (bullish skew)
Price downtrend
Key Context
Insider Activity
selling
Price Trend
downtrend
From 52w High
0.0%
Est. Revisions (30d)
+3.1% 2up/1dn
Analyst Target (mean)
$9 $3–$18 +307%
Options P/C Ratio
0.25
Est. Dispersion
32% 6 analysts
Insider Cluster
buy cluster
Fund Convergence
strong Renaissance, Two Sigma, Citadel
Recent Activity
insider trades
28 transactions
Sell
·
BERNS PAUL L (Chief Executive Officer)
·9,819 shares
·$34,459
Sell
·
AURORA DALJIT SINGH (Chief Operating Officer)
·6,165 shares
·$21,917
Sell
·
PINTO JOSHUA PH.D. (President)
·5,967 shares
·$21,093
Sell
·
MILLIGAN MICHAEL LEE (Chief Financial Officer)
·1,436 shares
·$5,119
Sell
·
AURORA DALJIT SINGH (Chief Operating Officer)
·114,703 shares
·$307,026
23 more
Buy
·
BUROW KRISTINA M
·1,915,700 shr
·$4,999,977
Buy
·
ARCH VENTURE PARTNERS XII, LLC
·1,915,700 shr
·$4,999,977
Other
·
PINTO JOSHUA PH.D.
·13,202 shr
Sell
·
BERNS PAUL L
·13,871 shr
·$23,468
Sell
·
AURORA DALJIT SINGH
·8,565 shr
·$14,347
Sell
·
LENZ ROBERT A
·5,614 shr
·$9,383
Sell
·
PINTO JOSHUA PH.D.
·8,048 shr
·$13,477
Sell
·
MILLIGAN MICHAEL LEE
·1,978 shr
·$3,351
Other
·
BERNS PAUL L
·399,291 shr
Sell
·
FUST MATTHEW K.
·21,788 shr
·$370,962
Exercise
·
FUST MATTHEW K.
·21,788 shr
·$127,039
Sell
·
LENZ ROBERT A
·13,823 shr
·$208,110
Sell
·
LENZ ROBERT A
·41,464 shr
·$492,827
Sell
·
LENZ ROBERT A
·32,948 shr
·$376,665
Sell
·
PINTO JOSHUA PH.D.
·15,693 shr
·$178,806
Sell
·
PINTO JOSHUA PH.D.
·84,307 shr
·$984,061
Award
·
BUROW KRISTINA M
·20,100 shr
Award
·
PIACQUAD DAVID A.
·20,100 shr
Award
·
HO MAYKIN
·20,100 shr
Award
·
FUST MATTHEW K.
·20,100 shr
Award
·
HALAWA ALAA A.
·20,100 shr
Other
·
AURORA DALJIT SINGH
·114,703 shr
Other
·
PINTO JOSHUA PH.D.
·238,965 shr
Explore more
